Spironolactone 5-mg/mL in Suspendit Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s): 152

Spironolactone 5-mg/mL in Suspendit Oral Suspension Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Spironolactone 5-mg/mL in Suspendit Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, spironolactone, potassium-sparing diuretic, antihypertensive agent, hypertension, high blood pressure, edema, liquid dosage form

Related Categories: DERMATOLOGY, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, CARDIOLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 248
Basics of Compounding: Foam Dosage Forms Allen Loyd V Jr	Jul/Aug 2013 Pg. 312-322
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Gupta Vishnu D, Ling Jie	May/Jun 2001 Pg. 232-233